Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America

Keyphrases

• Aggressive Management 33%
• AIDS-related 100%
• Antifungal Combination 33%
• Antigen Screening 33%
• Antigen Test 33%
• Antiretroviral Therapy Initiation 33%
• Case Fatality Rate 33%
• Cryptococcal Antigen 66%
• Cryptococcal Meningitis 100%
• Cryptococcosis 33%
• Cryptococcus 66%
• Early Mortality 33%
• Fluconazole 33%
• Health Care Costs 33%
• Highly Active Antiretroviral Therapy (HAART) 100%
• Induction Therapy 33%
• Infection Rate 33%
• Intracranial Pressure 33%
• Late HIV Diagnosis 33%
• Latin America (LATAM) 100%
• Number of Deaths 33%
• Optimal Treatment 33%
• Pressure Treatment 33%
• Retention in Care 33%

Medicine and Dentistry

• Antifungal Agent 33%
• Antigen 33%
• Case Fatality Rate 33%
• Cryptococcal Meningitis 100%
• Cryptococcosis 33%
• Diagnosis 33%
• Fluconazole 33%
• Health Care Cost 33%
• Highly Active Antiretroviral Therapy 100%
• Human Immunodeficiency Virus 33%
• Infection 66%
• Intracranial Pressure 33%